Brief: Anuh Pharma Granted Certificate Of Suitability From EDQM For Sulfadimethoxine
05/12/2025 06:35
Dec 5 (Reuters) - Anuh Pharma Ltd ANUH.NS: ANUH PHARMA LTD - GRANTED CERTIFICATE OF SUITABILITY FROM EDQM FOR SULFADIMETHOXINE Source text: ID:nBSE4zjC0N Further company coverage: ANUH.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anuh Pharma
See all newsBrief: Anuh Pharma Receives Possession Of Manufacturing Facility From Vanquest Pharma In Maharashtra
Brief: Anuh Pharma Signs Asset Transfer Agreement To Purchase Manufacturing Facility From Vanquest Pharma
Brief: Anuh Pharma Approves Investment In Manufacturing Assets To Expand Production Capacity
Brief: Anuh Pharma Says Maharashtra Facility Undergone Audit By EDQM
Brief: Anuh Pharma Granted Certificate Of Suitability From EDQM For Sulfadimethoxine